drugset / Trial / NCT07111013
A Study to Assess the Long-Term Safety of Lifitegrast/Perfluorohexyloctane Fixed-Dose Combination in Subjects With Dry Eye Disease
NaSingle-groupOpen-labelTreatment
Summary
A Study to Assess the Long-Term Safety of Lifitegrast/Perfluorohexyloctane Fixed-Dose Combination in Subjects With Dry Eye Disease
Timeline
- Start
- 2025-12
- Primary completion
- 2027-04
- Completion
- 2027-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lifitegrast | Unknown | 5 % | Topical |
| Subject | Perfluorohexyloctane | Unknown | 95 % | Topical |